Highland Life Sciences
0760.496.727 · rovalta.com · 20/09/2026
Highland Life Sciences
Overview
What does Highland Life Sciences do?
Highland Life Sciences is a Private limited company incorporated in 2020. Its main activity is: Management consultancy activities. Its registered office is in Lasne.
1380 Lasne · WallonieSee on map
Trend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 183,0 k € | -8.5% | 200,0 k € | -9.2% | 220,2 k € | +15.5% | 190,6 k € | -37.4% | 304,4 k € |
| EBITDA | 182,3 k € | -8.8% | 199,8 k € | -8.9% | 219,5 k € | +15.4% | 190,2 k € | -37.4% | 303,7 k € |
| Operating result | 181,6 k € | -8.8% | 199,1 k € | -9.3% | 219,5 k € | +15.4% | 190,2 k € | -37.4% | 303,7 k € |
| Net result | 141,6 k € | +3.7% | 136,5 k € | -8.8% | 149,7 k € | +78.0% | 84,1 k € | -63.9% | 232,7 k € |
| Balance sheet | |||||||||
| Equity | 520,6 k € | +37.4% | 379,0 k € | -19.1% | 468,4 k € | +47.0% | 318,7 k € | +35.8% | 234,7 k € |
| Total assets | 601,1 k € | -18.9% | 741,5 k € | +32.6% | 559,3 k € | +14.0% | 490,6 k € | +48.7% | 329,9 k € |
| Cash | 81,3 k € | +5.0% | 77,4 k € | +1108% | 6,4 k € | -97.6% | 268,0 k € | +77.4% | 151,1 k € |
| Debts | 80,6 k € | -77.8% | 362,5 k € | +299% | 90,9 k € | -46.3% | 169,4 k € | +97.0% | 86,0 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active
Active mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Hauteterre CS● Active | 0786.802.038 |
mazerine Partners● Active | 0862.242.304 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 22/12/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 13 months |
| Filing date | 27/07/2026 | 31/07/2025 | 09/08/2024 | 26/07/2023 | 13/07/2022 |
| General meeting | 05/06/2026 | 06/06/2025 | 07/06/2024 | 02/06/2023 | 11/07/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
5 filings with the NBB
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other28/12/2020RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025141,6 k €↑
- 2024Annual accounts 2024136,5 k €↓
- 2023Annual accounts 2023149,7 k €↑
- 2022Annual accounts 202284,1 k €↓
- 2021Annual accounts 2021232,7 k €
- 23/12/2020IncorporationPrivate limited company